Measurement of sleep apnea duration and evaluation of response therapies using duration metrics

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6881192
SERIAL NO

10170384

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An implantable cardiac device is programmed to detect an episode of sleep apnea, measure the duration of the episode, and store this information in memory. When multiple episodes are recorded, the device computes statistics on the apnea durations, such as average apnea duration and total apnea duration for a preselected time period (e.g., 8-hour rest period, 24-hour day, etc.). The implantable cardiac device may further be used to administer pacing therapy in response to detecting sleep apnea. Under the control of a physician, the implantable device may be programmed to administer different types of responsive therapies to evaluate whether certain therapies are more effective at treating apnea than others. For instance, a pacing therapy that results in lowering the average apnea duration or total apnea duration may be preferred over other pacing therapies that do not achieve such results.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PACESETTER INC15900 VALLEY VIEW COURT SYLMAR CA 91342

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Park, Euljoon Stevenson Ranch, CA 126 7469

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation